FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083437 [Registered on: 25/03/2025] Trial Registered Prospectively
Last Modified On: 01/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Compare two different densities of a drug in spinal anesthesia for surgeries to determine which one is better 
Scientific Title of Study   Prospective Randomized Double Blind Comparative Study between the efficacy of intrathecal 0.5 persent bupivacaine heavy vs isobaric in infraumblical surgeries 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  BALASAHEB GOVERDHANE 
Designation  Professor 
Affiliation  D Y PATIL HOSPITAL 
Address  Second floor, A Block, Department of anesthesia, D Y Patil hospital , Dr D Y Patil Vidyanagar , sector 5,Nerul,navimumbai.

Thane
MAHARASHTRA
400706
India 
Phone  09819631719  
Fax    
Email  gbalasaheb690@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  BALASAHEB GOVERDHANE 
Designation  Professor 
Affiliation  D Y PATIL HOSPITAL 
Address  Second floor, A Block, Department of anesthesia, D Y Patil hospital, Dr D Y Patil Vidyanagar, sector 5,Nerul,navimumbai.

Thane
MAHARASHTRA
400706
India 
Phone  09819631719  
Fax    
Email  gbalasaheb690@gmail.com  
 
Details of Contact Person
Public Query
 
Name  GUNJU REDDY SAI 
Designation  JUNIOR RESIDENT 
Affiliation  D Y PATIL HOSPITAL 
Address  Second floor, A Block, Department of anesthesia, D Y Patil hospital, Dr D Y Patil Vidyanagar, sector 5, Nerul, Navi Mumbai.

Thane
MAHARASHTRA
400706
India 
Phone  09819631719  
Fax    
Email  reddysaigunju@gmail.com  
 
Source of Monetary or Material Support  
D Y PATIL HOSPITAL, sector 7, nerul, navi mumbai,maharastra, pin:400706 
 
Primary Sponsor  
Name  D Y Patil Hospital 
Address  Second floor,A Block,Department of anesthesia,D Y Patil hospital,ayyappa Temple Rd,Dr D Y Patil vidhyanagar,sector 5,Nerul,navimumbai. 400706 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr GUNJU REDDY SAI  D Y Patil hospital  2nd floor, operation theatre complex, D Y Patil Hospital
Thane
MAHARASHTRA 
7989314708

reddysaigunju@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee for Biomedical and Health Research D Y Patil deemed to be university School of Medicine, Navi Mumbai  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  HYPERBARIC BUPIVACAINE  INJ.BUPIVACAINE 0.5 percent HEAVY 3ML as spinal drug in spinal anesthesia in 12 patients 
Intervention  ISOBARIC BUPIVACAINE  PLAINE BUPIVACAINE 0.5 percent 3ML as spinal drug in spinal anesthesia in 12 patients 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  undergoing elective infraumblical abdominal surgeries under ASA-II 
 
ExclusionCriteria 
Details  Patients undergoing emergency surgeries.
Patients known or suspected to have allergy for study drugs.
Patient refusal.
Patients with contraindications to spinal anesthesia.
History of neurological disorders
Pregnancy or lactation
History of chronic pain or chronic opioid use
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Alternation 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
the time of onset, the level and the duration of block obtained (both sensory and motor) between isobaric versus hyperbaric bupivacaine.  at base line,2min,4 min,6 min,8 min,10 min,15 min,20 min,25min, 30 min,40 min,50 min,60 min 
 
Secondary Outcome  
Outcome  TimePoints 
the effects of both the drugs on heamodynamic parameters (heart rate & blood pressure) & side effects  at base line,2min,4 min,6 min,8 min,10 min,15 min,20 min,25min, 30 min,40 min,50 min,60 min 
 
Target Sample Size   Total Sample Size="24"
Sample Size from India="24" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/04/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   INTRODUCTION:

       Bupivacaine is a local anesthetic that is largely used for spinal anesthesia, mainly as a hyperbaric or plain solution, Controversy exists regarding the predictability of the levels of analgesia achieved with isobaric bupivacaine solution when compared to hyperbaric bupivacaine.

 

       Local anesthetics used for spinal anesthesia are mostly available as hyperbaric solutions and it is well established that the addition of dextrose to increase the specific gravity of the solutions alters the anesthetic profiles.

 

 

       Position of the patient and baricity or density of the local anesthetic solution injected as determinants of distribution.

 

     The sitting position is frequently used for induction of spinal anesthesia. Hyperbaric solutions, under the influence of gravity, would be expected  to spread caudally whereas isobaric solutions would be expected to distribute rostrally.

This study aims to conduct a comprehensive comparative analysis between 0.5% bupivacaine heavy and 0.5% bupivacaine plain in elective infra umbilical abdominal surgeries, focusing on their respective duration of sensory and motor blockade,hemodynamic stability


                         AIMS  AND OBJECTIVES

 

   Comparing the clinical efficacy between hyperbaric 0.5% bupivacaine vs isobaric 0.5% bupivacaine during elective infra umblical abdominal surgeries.

  Primary objective:

 

To compare the time of onset, the level and the duration of block obtained (both sensory and motor) between isobaric versus hyperbaric bupivacaine

   Secondary objective:

To compare the effects of both the drugs on heamodynamic parameters (heart rate and blood pressure) and side effects


STUDY PROCEDURE:

 

 Patients of undergoing elective infra umbilical abdominal surgeries planned under spinal anaesthesia who give written informed consent for the study, will be recruited and randomized based on a computer generated model.

After thorough clinical assessment and routine investigations , they will be randomly allocated into two groups containing 12 patients each. And for the purposes of the investigation will be unaware of the groups they will be allotted into.

 Group A will receive spinal anesthesia using intrathecal 3ml 0.5% isobaric bupivacaine

 Group B will receive spinal anesthesia using intrathecal 3ml 0.5%  hyperbaric bupivacaine

 On arrival in the anesthesia room  the IV cannula will be secured. ECG , non invasive arterial pressure (SBP,DBP,MAP) and pulse oximetry will be monitored .Baseline values will be noted. patients were preloaded with 10 ml/kg of Ringer’s lactate over 10 min.

 For blinding purposes, the primary anesthetist will be responsible for the randomization of the patients and the drug whereas the other investigator ( unaware of the group allocation and the drug administered) will be responsible for the induction of anesthesia as well as data collection.

After the injection of the spinal drug  the assessments of sensory block will be done by pinprick test  and Results of the pinprick test will be determined bilaterally at midclavicular level by using a short- beveled 27-gauge needle. Motor block in the lower limb was assessed by using a modified Bromage scale . These assessments will be performed immediately after the assessments of sensory block until the return of normal motor function.

After the injection of the spinal medication, heart rate and arterial blood pressure will be measured/recorded at 2min interval for first 10 minutes, 5min for the next 10 minutes and 10min intervals thereafter until 60 min post administration of drug.

 In case of hypotension (systolic blood pressure (SBP) < 90 mmHg or a decrease in SBP BY 20% of the baseline value), will be managed by rapid infusion of 250 ml of Ringers lactate and 3 mg incremental doses of intra venous  inj ephiderine . Similarly in case of bradycardia(HR<50 BPM) , will be managed with incremental doses of 0.3 mg intravenous atropine

The onset of sensory block is defined as the time taken for loss of sharp sensation with the pinprick test until the T8  dermatome level after injecting the drug (TT8 ).

The time of regression is defined as the time taken for regression of the block to two segments after injecting the drug was noted (Treg2 ).

The time taken to achieve ad equate motor block (TBrom2 ), defined as a score of 2 on the modified Bromage scale, was recorded by testing the motor block every minute until a score of 2 was achieved.

Surgery will be commenced once adequate sensory (T8) and motor (modified Bromage 2) block was achieved. The quality of surgical anesthesia was scored as follows depending on the pa tient’s response:

          Excellent (Score 4): No complaint from the patient.

          Satisfactory (Score 3): Patient allowed the surgery but sometimes complained of uneasiness, requiring supplemental analgesia        with intravenous fentanyl (0.5 µg/kg bolus)  maxi mum 4 µg/kg.

         Inadequate (Score 2): Patient complained of pain and re quired conversion to general anesthesia.

          Failure (Score 1): Adequate sensory level or motor block not achieved.

      An incision will made once the sensory block of at least T6 level was achieved, along with motor block of modified Brom age grade 2 (10) or less. If these were not achieved in 20 min, it was considered failed spinal anesthesia and converted to general anesthesia.

      The duration of anesthesia (Tanes ) is defined as the time interval between the onset of sensory block (T8 level) to regression of the sensory block to the L1 dermatome.

      The duration of the motor block (TMB ) is defined as the time interval between the onset of motor block (modified Bromage scale 2) to the achievement of modified Bromage scale 6 after the surgery.

      The time interval between administration of the subarachnoid block and the first request for supplemental analgesia by the patient will be noted as the duration of effective analgesia (Tanalg)

 

 

 
Close